Clinical Trial Update: Metformin and 5-fluorouracil for Refractory Colorectal Cancer. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of metformin and 5-fluorouracil in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• metformin (metformin)

Snippet

Sponsor: Instituto do Cancer do Estado de São Paulo | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED